Predictors of lung transplant waitlist mortality for sarcoidosis

Abstract

RationaleUnlike in other chronic lung diseases, criteria for lung transplant referral in sarcoidosis is not well-established. Waitlist mortality may offer clues in identifying clinical factors that warrant early referral. We aim to identify predictors for transplant waitlist mortality to improve referral criteria for patients with sarcoidosis. MethodsWe conducted a retrospective analysis of 1034 sarcoidosis patients listed for lung transplantation from May 2005 to May 2019 in the Scientific Registry of Transplant Recipients (SRTR) database. All patients were listed after the establishment of the Lung Allocation Score (LAS). We compared patients who died on the transplant waitlist to those who survived to transplantation. Potential predictors of waitlist mortality were assessed utilizing univariate and multivariate analysis performed via logistic regression modeling. ResultsOf 1034 candidates listed after LAS implementation, 704 were transplanted and 110 died on the waitlist. Significant predictors of waitlist mortality on multivariate analysis include female gender (OR 2.445; 95% CI 1.513–3.951; p = 0.0003) and severe pulmonary hypertension (OR 1.619; 95% CI 1.067–2.457; p = 0.0236). Taller minimum donor height (OR 0.606; 95% CI 0.379–0.969; p = 0.0365) and blood type B (OR 0.524; 95% CI 0.281–0.975 p = 0.0415) were associated with decreased likelihood of death on the waitlist. ConclusionAmong patients with sarcoidosis on the lung transplant waitlist, taller minimum donor height and blood type B were found to be protective factors against death on the waitlist. Female gender and severe pulmonary hypertension have a higher likelihood of death and earlier referral for transplantation in patients with these characteristics should be considered.